Had to laugh, I saw the news come out and when it came out of the pause in trading there were some big buys and then a few sold down, no problem if you want to sell, but why would you do it just after your investment was significantly derisked by getting ethics approval for human trials?
Anyway this head to head battle for bioavailability is going to be really interesting, a more pure product that is more easy to uptake, than the only other approved product in that space. Potentially huge runway from there. I am fairly comfortable around safety, CBD is not new, but as we get better at understanding its application in mental health, the nuances between types of CBD are going to become very important.
Exciting times.
Add to My Watchlist
What is My Watchlist?
